newsfilter
← Latest News
GlobeNewswire·

Celyad Oncology Announces Intent to Voluntarily Delist American Depository Shares From Nasdaq

MONT-SAINT-GUIBERT, Belgium, May 05, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology ((Euronext &, NASDAQ:CYAD) (the "Company"), a biotechnology company focused on innovative technologies for chimeric antigen receptor